Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling

Brain, Behavior, and Immunity

Volumn 26, Issue 4, 2012, Pages 635-641

  Lamkin, Donald M ^a   Sloan, Erica K ^a,b,c   Patel, Ami J ^a   Chiang, Beverley S ^a   Pimentel, Matthew A ^a   Ma, Jeffrey C Y ^a,c   Arevalo, Jesusa M ^a,c   Morizono, Kouki ^c   Cole, Steve W ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adrenergic receptor; Acute lymphoblastic leukemia; Bioluminescent imaging; Hematopoiesis; Pediatrics; Propranolol; Restraint stress; Sympathetic nervous system

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; LUCIFERASE; MESSENGER RNA; NORADRENALIN; PROPRANOLOL;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BIOLUMINESCENCE; BONE MARROW; CANCER GROWTH; CANCER MODEL; CELL PROLIFERATION; CHRONIC STRESS; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMOBILIZATION STRESS; LEUKEMIA CELL; MALE; METASTASIS; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR ENGRAFTMENT; TUMOR MICROENVIRONMENT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CELL LINE, TUMOR; CYCLIC AMP; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; LEUKEMIA, EXPERIMENTAL; MALE; MICE; MICE, SCID; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-3; RESTRAINT, PHYSICAL; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 84859426449     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.01.013     Document Type: Article

References (41)

1. Antoni M.H., Lutgendorf S.K., Cole S.W., Dhabhar F.S., Sephton S.E., McDonald P.G., Stefanek M., Sood A.K. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat. Rev. Cancer 2006, 6:240-248.
2. Armaiz-Pena G.N., Lutgendorf S.K., Cole S.W., Sood A.K. Neuroendocrine modulation of cancer progression. Brain Behav. Immun. 2009, 23:10-15.
3. Avraham R., Inbar S., Rosenne E., Ben-Eliyahu S. Autologous control of a highly malignant syngeneic CRNK-16 leukemia in the rat: a role for NK cells. Cancer Immunol. Immunother. 2006, 55:1348-1357.
4. Ben-Eliyahu S., Page G.G., Yirmiya R., Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer 1999, 80:880-888.
5. Chida Y., Hamer M., Wardle J., Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival?. Nat. Clin. Pract. Oncol. 2008, 5:466-475.
6. Cole S.W., Jamieson B.D., Zack J.A. CAMP up-regulates cell surface expression of lymphocyte CXCR4: implications for chemotaxis and HIV-1 infection. J. Immunol. 1999, 162:1392-1400.
7. Cole S.W., Korin Y.D., Fahey J.L., Zack J.A. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J. Immunol. 1998, 161:610-616.
8. Colmone A., Amorim M., Pontier A.L., Wang S., Jablonski E., Sipkins D.A. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 2008, 322:1861-1865.
9. Felten S.Y., Felten D.L. Innervation of lymphoid tissue. Psychoneuroimmunology 1991, 27-68. Academic Press, San Diego. second ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
10. Ganju R.K., Shpektor R.G., Brenner D.G., Shipp M.A. CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src-related kinase. Blood 1996, 88:4159-4165.
11. Glasner A., Avraham R., Rosenne E., Benish M., Zmora O., Shemer S., Meiboom H., Ben-Eliyahu S. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J. Immunol. 2010, 184:2449-2457.
12. Gotoh T., Lee G., Yoshikura H. Effects of physical restraint on leukemogenesis by Friend virus. Jpn. J. Cancer Res. 1986, 77:985-991.
13. Hermann G., Beck F.M., Tovar C.A., Malarkey W.B., Allen C., Sheridan J.F. Stress-induced changes attributable to the sympathetic nervous system during experimental influenza viral infection in DBA/2 inbred mouse strain. J. Neuroimmunol. 1994, 53:173-180.
14. Inbar S., Neeman E., Avraham R., Benish M., Rosenne E., Ben-Eliyahu S. Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS One 2011, 6:e19246.
15. Jensen M.M. The influence of stress on murine leukemia virus infection. Proc. Soc. Exp. Biol. Med. 1968, 127:610.
16. Katayama Y., Battista M., Kao W.M., Hidalgo A., Peired A.J., Thomas S.A., Frenette P.S. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006, 124:407-421.
17. Kazak A.E., Boyer B.A., Brophy P., Johnson K., Scher C.D., Covelman K., Scott S. Parental perceptions of procedure-related distress and family adaptation in childhood leukemia. Child Health Care 1995, 24:143-158.
18. Kolenova A., Hikkel I., Ilencikova D., Hikkelova M., Sejnova D., Kaiserova E., Cizmar A., Puskacova J., Bubanska E., Oravkinova I., Gencik M. Minimal residual disease detection using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: Slovak experience. Neoplasma 2010, 57:552-561.
19. Leukemia & Lymphoma Society Facts 2010-2011 2010, The Leukemia & Lymphoma Society, White Plains, NY.
20. Madden K.S., Szpunar M.J., Brown E.B. β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines. Breast Cancer Res. Treat. 2011, 130:747-758.
21. Mamani-Matsuda M., Moynet D., Molimard M., Ferry-Dumazet H., Marit G., Reiffers J., Mossalayi M.D. Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells. Br. J. Haematol. 2004, 124:141-150.
22. Manni L., Di Fausto V., Fiore M., Aloe L. Repeated restraint and nerve growth factor administration in male and female mice: effect on sympathetic and cardiovascular mediators of the stress response. Curr. Neurovasc. Res. 2008, 5:1-12.
23. Melamed R., Rosenne E., Shakhar K., Schwartz Y., Abudarham N., Ben-Eliyahu S. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav. Immun. 2005, 19:114-126.
24. Mendez-Ferrer S., Lucas D., Battista M., Frenette P.S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452:442-447.
25. Morizono K., Xie Y., Ringpis G.E., Johnson M., Nassanian H., Lee B., Wu L., Chen I.S. Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat. Med. 2005, 11:346-352.
26. Nahar R., Müschen M. Pre-B cell receptor signaling in acute lymphoblastic leukemia. Cell Cycle 2009, 8:3874-3877.
27. Nance D.M., Sanders V.M. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav. Immun. 2007, 21:736-745.
28. Pui C.H. Acute lymphoblastic leukemia: introduction. Semin. Hematol. 2009, 46:1-2.
29. Pui C.H., Robison L.L., Look A.T. Acute lymphoblastic leukaemia. Lancet 2008, 371:1030-1043.
30. Rasmussen A.F. Emotions and immunity. Ann. NY Acad. Sci. 1969, 164:458-462.
31. Romanski A., Bug G., Becker S., Kampfmann M., Seifried E., Hoelzer D., Ottmann O.G., Tonn T. Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia. Exp. Hematol. 2005, 33:344-352.
32. Sawyers C.L., Denny C.T., Witte O.N. Leukemia and the disruption of normal hematopoiesis. Cell 1991, 64:337-350.
33. Shelby M.D., Nagle R.J., Barnett-Queen L.L., Quattlebaum P.D., Wuori D.F. Parental reports of psychosocial adjustment and social competence in child survivors of acute lymphocytic leukemia. Child Health Care 1998, 27:113-129.
34. Sipkins D.A., Wei X., Wu J.W., Runnels J.M., Côté D., Means T.K., Luster A.D., Scadden D.T., Lin C.P. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 2005, 435:969-973.
35. Sloan E.K., Priceman S.J., Cox B.F., Yu S., Pimentel M.A., Tangkanangnukul V., Arevalo J.M., Morizono K., Karanikolas B.D., Wu L., Sood A.K., Cole S.W. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010, 70:7042-7052.
36. Smagin G.N., Howell L.A., Redmann S., Ryan D.H., Harris R.B. Prevention of stress-induced weight loss by third ventricle CRF receptor antagonist. Am. J. Physiol. 1999, 276:R1461-R1468.
37. Stefanski V., Ben-Eliyahu S. Social confrontation and tumor metastasis in rats: defeat and beta-adrenergic mechanisms. Physiol. Behav. 1996, 60:277-282.
38. Thaker P.H., Han L.Y., Kamat A.A., Arevalo J.M., Takahashi R., Lu C., Jennings N.B., Armaiz-Pena G., Bankson J.A., Ravoori M., Merritt W.M., Lin Y.G., Mangala L.S., Kim T.J., Coleman R.L., Landen C.N., Li Y., Felix E., Sanguino A.M., Newman R.A., Lloyd M., Gershenson D.M., Kundra V., Lopez-Berestein G., Lutgendorf S.K., Cole S.W., Sood A.K. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 2006, 12:939-944.
39. Thaker P.H., Sood A.K. Neuroendocrine influences on cancer biology. Semin. Cancer Biol. 2008, 18:164-170.
40. Vogelstein B., Kinzler K.W. The Genetic Basis of Human Cancer 2002, McGraw Hill, New York. second ed.
41. Willingham-Piersol L., Johnson A., Wetsel A., Holtzer K., Walker C. Decreasing psychological distress during the diagnosis and treatment of pediatric leukemia. J. Pediatr. Oncol. Nurs. 2008, 25:323-330.